吉林市治男科医院吉林哪家医院割包皮的比较好,吉林神经性尿频,吉林男科医院哪个较正规,吉林医院男科疾病问答,吉林治疗阴茎上小红点多少钱,吉林做包皮包茎手术医院,吉林割包皮过长医院地址在哪

BEIJING, May 16 (Xinhua) -- An initial ruling by China's Ministry of Commerce said Monday that European Union (EU) members have subsidized potato starch exports to China, hurting the interests of China's domestic industries.China will impose an anti-subsidy provision of the tariff on potato starch products effective from May 19, the ministry said in a statement on its website. The rate will range between 7.7 percent and 11.19 percent, depending on the subsidy margin, according to the statement.The initial ruling accused several EU companies, including France's Roquette Freres and Netherland's AVEBE, of receiving subsidies.China launched an anti-subsidy investigation into potato starch imports from the EU on August 30, 2010 at the request of the China Starch Industry Association. This was China's first-ever anti-subsidy probe into imports from the EU.China had earlier decided to impose anti-dumping tariffs ranging from 12.6 percent to 56.7 percent on EU potato starch products. The new tariffs were effective from April 19.

QINGDAO, Jan. 23 (Xinhua) -- Haier Group, one of the world's leading white goods and household appliance manufacturers, announced Sunday that its profit jumped 78 percent year on year in 2010.The profit hit 6.2 billion yuan (941.8 million U.S. dollars) in 2010, said Du Fangyuan, a press office coordinator of the company.Haier's sales revenue reached 135 billion yuan in 2010, up nine percent from a year earlier, Du said.The growth can be attributed to the group's successful transition of business model and product innovations, Du said.Haier Group, which is headquartered in east China's Qingdao city and has 60,000 global employees, sells its products in over 100 countries and regions around the world.

WASHINGTON, March 25 (Xinhua) -- NASA's Stardust spacecraft depleted fuel and ceased operation on Thursday after a 12-year run, the U.S. space agency said Friday."This is the end of the spacecraft's operations, but really just the beginnings of what this spacecraft's accomplishments will give to planetary science," said Lindley Johnson, Stardust-NExT and Discovery program executive at NASA headquarters in Washington."The treasure-trove of science data and engineering information collected and returned by Stardust is invaluable for planning future deep space planetary missions."Artist's concept of Stardust spacecraft nearing EarthLaunched on Feb. 7, 1999, Stardust flew past the asteroid named Annefrank and traveled halfway to Jupiter to collect the particle samples from the comet Wild 2. The spacecraft returned to Earth's vicinity to drop off a sample return capsule eagerly awaited by comet scientists.NASA re-tasked the spacecraft as Stardust-NExT to perform a bonus mission and fly past comet Tempel 1, which was struck by the Deep Impact mission in 2005. The mission collected images and other scientific data to compare with images of that comet collected by the Deep Impact.The Stardust-NExT met all mission goals, and the spacecraft was extremely successful during both missions. From launch until final rocket engine burn, it travelled approximately 3.54 billion miles.After the mileage logged in space, the Stardust team knew the end was near for the spacecraft. With its fuel tank empty and final radio transmission concluded, the most traveled comet hunter will move from NASA's active mission roster to retired."This kind of feels like the end of one of those old western movies where you watch the hero ride his horse toward the distant setting sun -- and then the credits begin to roll," said Stardust-NExT project manager Tim Larson from NASA's Jet Propulsion Laboratory in Pasadena, California. "Only there's no setting sun in space."

BEIJING, March 24 (Xinhuanet) -- A new study has found that Actos, a medicine treats onset diabetes, could also reduce the diabetes risk in people with prediabetes.The study, which was published Wednesday in New England Journal of Medicine, followed 602 prediabetics whose obesity, ethnicity, family history and other factors put them at high risk of developing diabetes.The research findings showed that Actos, generically known as pioglitazone, reduced the odds of developing Type 2 diabetes by 72 percent in people with prediabetes.Only 2.1 percent of those who took Actos developed diabetes each year over the three years of the study, compared with 7.6 percent of those who took a placebo.Lead author of the study Ralph DeFronzo said, "The 72 percent reduction is the largest decrease in the conversion rate of pre-diabetes to (Type 2) diabetes that has ever been demonstrated by any intervention, be it diet, exercise or medication."However, Actos can have significant side effects, including water retention, moderate weight gain, and increased risk of bone fractures.

WASHINGTON, May 11 (Xinhua) -- NASA's Dawn spacecraft has obtained its first image of the giant asteroid Vesta, which will help fine-tune navigation during its approach, the U.S. space agency announced Wednesday.Dawn expects to achieve orbit around Vesta on July 16, when the asteroid is about 117 million miles from Earth.The image from Dawn's framing cameras was taken on May 3 when the spacecraft began its approach and was approximately 752,000 miles (1.21 million km) from Vesta. The asteroid appears as a small, bright pearl against a background of stars. Vesta also is known as a protoplanet, because it is a large body that almost formed into a planet."After plying the seas of space for more than a billion miles, the Dawn team finally spotted its target," said Carol Raymond, Dawn's deputy principal investigator at NASA's Jet Propulsion Laboratory in Pasadena, California. "This first image hints of detailed portraits to come from Dawn's upcoming visit."Vesta is 330 miles (530 km) in diameter and the second most massive object in the asteroid belt. Ground- and space-based telescopes obtained images of the bright orb for about two centuries, but with little surface detail.Mission managers expect Vesta's gravity to capture Dawn in orbit on July 16. To enter orbit, Dawn must match the asteroid's path around the sun, which requires very precise knowledge of the body's location and speed. By analyzing where Vesta appears relative to stars in framing camera images, navigators will pin down its location and enable engineers to refine the spacecraft's trajectory.Dawn will start collecting science data in early August at an altitude of approximately 1,700 miles (2,700 km) above the asteroid's surface. As the spacecraft gets closer, it will snap multi-angle images allowing scientists to produce topographic maps. Dawn will later orbit at approximately 120 miles (200 km) to perform other measurements and obtain closer shots of parts of the surface. Dawn will remain in orbit around Vesta for one year. After another long cruise phase, Dawn will arrive in 2015 at its second destination, Ceres, an even more massive body in the asteroid belt.Gathering information about these two icons of the asteroid belt will help scientists unlock the secrets of our solar system's early history. The mission will compare and contrast the two giant asteroids shaped by different forces. Dawn's science instruments will measure surface composition, topography and texture. Dawn also will measure the tug of gravity from Vesta and Ceres to learn more about their internal structures. The spacecraft's full odyssey will take it on a 3-billion-mile (5-billion-km) journey, which began with its launch in September 2007.